Quintiles leads several initiatives related to real-world research and registries, including developing user guides for AHRQ on using registries to evaluate patient outcomes and developing quality principles for observational research. Quintiles also leads efforts to create a central index of patient registries and assists in monitoring medical products in Europe. Quintiles participates in developing innovative methods in pharmacoepidemiology and helps collect and transmit adverse event data electronically.

1. Real-World & Late Phase Research
The right approach
for the right question
Observational research
& registries
Initiatives
AHRQ Registries User’s Guide –
www.effectivehealthcare.ahrq.gov
Quintiles leads the development of the
Agency for Healthcare Research and
Quality (AHRQ) user’s guide, Registries
for Evaluating Patient Outcomes.
AHRQ OCER User’s Guide –
www.effectivehealthcare.ahrq.gov
Quintiles leads the development of
AHRQ user’s guide, Developing a
Protocol for Observational Comparative
Effectiveness Research.
GRACE Principles –
www.graceprinciples.org (Good
ReseArch for Comparative Effectiveness)
Quintiles develops quality evaluation
principles for observational research.
ROPR (Registry of Patient Registries)
Quintiles leads the effort to create a
central index of patient registries.
ENCePP®
– www.encepp.eu
(European Network of Centres for
Pharmacoepidemiology and
Pharmacovigilance)
Quintiles assists the monitoring of
post-market medical products in Europe.
PROTECT-EU – www.imi-protect.eu
(Pharmacoepidemiological Research on
Outcomes of Therapeutics by a
European ConsorTium)
Quintiles helps develop innovative
methods in pharmacoepidemiology and
pharmacovigilance.
ASTER-D (Adverse Event Spontaneous
Triggered Electronic Reports for Devices)
Quintiles participates in a pilot approach
to collecting and transmitting adverse
event data electronically.
Connecting
insights
950 Medical Doctors
900 PhDs
13 Therapeutic Centers
of Excellence
Superior
delivery
Quintiles named as
Phase IV industry leader
in ISR 2014 report amongst
CRO Quality Benchmarking
Phase IV Service Providers
Better
outcomes
Quintiles helped develop or
commercialize 100% of the
Top 100 best-selling products
or compounds of 2013
Quintiles is a Fortune 500
company
Embrace
value-based
healthcare
Turn clinical evidence and
patient insight into a clear and
convincing value story
Maximize
commercial
value
Achieve and sustain peak
commercialization faster
through better market access
and channel strategies
Achieve
better patient
outcomes
Improve patient care using
real-world measures and
engagement
Access global
scale with local
knowledge
Leverage the industry’s
largest integrated service
infrastructure to gain local
insight and market access

2. Access to
>18M
Electronic
Health Records
through the COMPASS
network
Observational studies and
quality improvement
programs across
>70,000
sites since 2004
Performed quality
measurements for
13 patient
associations
and medical specialty
associations since 2001
Quintiles has worked on
41 rare
disease
registries
since 2004
Access to
>61M
patient lives
via Electronic Health
Records since 2004
125
patient
registries
and observational
studies since 2011
>14.7M
patients
in observational
and quality improvement
programs in >100
countries since 2004
>2,500
hospitals
in the American Heart
Association's Get With
The Guidelines®
quality
improvement program
>400
direct-to-
patient studies
in >30 countries since 2008
>500
Real-World
& Late Phase
Programs
since 2011
Experience of
44 post-
authorization
safety studies
(PASS)
>32,000
employees
operating in more than
100 countries
>14,500
HTA data
records
captured from 100 agencies
in 32 countries
Quintiles was named to
InformationWeek
Top 500 list
of Information Technology
Innovators for five
consecutive years
Quintiles has helped
gain market access for
>135
products
in the U.S. since 2003
Copyright©2015Quintiles.Allrightsreserved.19.0011-1-02.15